Avadel Pharmaceuticals (AVDL) Stock Chart & Stock Price History → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free AVDL Stock Alerts $15.11 -1.14 (-7.02%) (As of 11:34 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Avadel Pharmaceuticals Stock Price Performance5 Day Performance-19.71%1 Month Performance-9.90%3 Month Performance+4.79%6 Month Performance+36.13%Year-To-Date Performance+7.01%1 Year Performance+0.47% Receive AVDL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avadel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Huge AlertsThis 1 Biotech Stock has been shocking the marketsSave the Date: BioStem's 2024 Q1 Call Coming Up!Sign Up for the Live Broadcast here AVDL Stock Chart for Thursday, May, 9, 2024 AVDL Chart by TradingView Avadel Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$18.18$16.25-10.62%$17.85$15.654.21 million shs$1.47 billion05/07/2024$18.62$18.18-2.36%$18.77$17.831.50 million shs$1.65 billion05/06/2024$18.82$18.62-1.06%$19.07$18.46637,249 shs$1.69 billion05/03/2024$18.30$18.82+2.84%$19.09$17.91874,882 shs$1.70 billion05/02/2024$18.31$18.30-0.05%$18.66$17.73849,156 shs$1.66 billion05/01/2024$18.16$18.31+0.83%$19.04$18.231.03 million shs$1.66 billion Get the Latest News and Ratings for AVDL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avadel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$17.97$18.16+1.06%$18.65$17.85849,686 shs$1.64 billion04/29/2024$17.81$17.97+0.90%$18.26$17.82553,917 shs$1.63 billion04/26/2024$17.82$17.81-0.06%$18.22$17.71452,410 shs$1.61 billion04/25/2024$17.66$17.82+0.91%$17.86$16.95774,811 shs$1.61 billion04/24/2024$18.09$17.66-2.38%$18.45$17.52443,600 shs$1.60 billion04/23/2024$17.30$18.09+4.57%$18.19$17.26985,700 shs$1.64 billion04/22/2024$17.33$17.30-0.17%$17.65$16.70823,396 shs$1.57 billion04/19/2024$17.38$17.33-0.29%$17.86$17.181.33 million shs$1.57 billion04/18/2024$17.99$17.38-3.39%$18.17$17.021.11 million shs$1.57 billion04/17/2024$18.09$17.99-0.55%$18.47$17.401.61 million shs$1.63 billion04/16/2024N/A$18.09$18.85$16.522.32 million shs$1.64 billion04/12/2024$15.96$15.99+0.19%$16.00$15.321.47 million shs$1.45 billion04/11/2024$16.15$15.96-1.18%$16.38$15.26981,311 shs$1.45 billion04/10/2024$16.77$16.15-3.70%$16.60$15.95460,807 shs$1.46 billion04/09/2024$17.13$16.77-2.10%$17.42$16.66471,201 shs$1.52 billion04/08/2024$16.69$17.13+2.64%$17.19$16.41667,450 shs$1.55 billion04/05/2024$16.59$16.69+0.60%$16.71$16.05427,609 shs$1.51 billion04/04/2024$16.29$16.59+1.84%$16.89$16.06446,651 shs$1.50 billion04/03/2024$16.41$16.29-0.73%$16.57$15.92371,236 shs$1.48 billion04/02/2024$16.66$16.41-1.50%$16.68$16.22452,755 shs$1.49 billion04/01/2024$16.89$16.66-1.36%$17.00$16.14789,165 shs$1.51 billion03/29/2024$16.89$16.89$17.23$16.66510,834 shs$1.53 billion03/28/2024$16.84$16.89+0.30%$17.23$16.66510,834 shs$1.53 billion03/27/2024$16.24$16.84+3.69%$16.86$16.26355,913 shs$1.53 billion03/26/2024$16.59$16.24-2.11%$16.89$16.20462,101 shs$1.47 billion03/25/2024$17.22$16.59-3.66%$17.47$16.50783,227 shs$1.50 billion03/22/2024$17.09$17.22+0.76%$17.44$16.95917,900 shs$1.55 billion03/21/2024$16.57$17.09+3.14%$17.09$16.561.19 million shs$1.53 billion03/20/2024$15.80$16.57+4.87%$16.74$15.75662,368 shs$1.49 billion03/19/2024$15.77$15.80+0.19%$15.98$15.62402,042 shs$1.42 billion03/18/2024$15.92$15.77-0.94%$16.10$15.70655,482 shs$1.42 billion03/15/2024$16.10$15.92-1.12%$16.46$15.90685,709 shs$1.43 billion03/14/2024$16.08$16.10+0.12%$16.19$15.80887,268 shs$1.45 billion03/13/2024$15.97$16.08+0.69%$16.27$15.82981,012 shs$1.44 billionThis 1 Biotech Stock has been shocking the markets (Ad)Save the Date: BioStem's 2024 Q1 Call Coming Up!Sign Up for the Live Broadcast here03/12/2024$16.00$15.97-0.19%$16.16$15.731.44 million shs$1.43 billion03/11/2024$16.35$16.00-2.14%$16.53$15.96667,760 shs$1.44 billion03/08/2024$16.04$16.35+1.96%$16.70$15.541.08 million shs$1.47 billion03/07/2024$16.32$16.04-1.75%$16.72$15.851.27 million shs$1.44 billion03/06/2024$15.81$16.32+3.23%$16.67$15.572.28 million shs$1.47 billion03/05/2024$16.13$15.81-1.98%$16.50$15.652.09 million shs$1.42 billion03/04/2024$13.72$16.13+17.57%$17.00$11.8210.23 million shs$1.45 billion03/01/2024$12.78$13.72+7.36%$13.86$12.364.11 million shs$1.23 billion02/29/2024$12.55$12.78+1.83%$13.01$12.541.61 million shs$1.15 billion02/28/2024$13.31$12.55-5.71%$13.36$12.432.03 million shs$1.13 billion02/27/2024$12.99$13.31+2.46%$13.44$12.931.34 million shs$1.20 billion02/26/2024$12.62$12.99+2.93%$13.02$12.601.35 million shs$1.17 billion02/23/2024$12.60$12.62+0.16%$13.05$12.481.53 million shs$1.13 billion02/22/2024$12.68$12.60-0.63%$13.03$12.53970,201 shs$1.13 billion02/21/2024$12.86$12.68-1.40%$13.20$12.571.06 million shs$1.14 billion02/20/2024$13.57$12.86-5.23%$13.60$12.581.44 million shs$1.15 billion02/19/2024$13.57$13.57$14.11$13.51641,100 shs$1.22 billion02/16/2024$14.20$13.57-4.44%$14.11$13.51640,105 shs$1.22 billion02/15/2024$14.25$14.20-0.35%$14.36$14.15647,496 shs$1.28 billion02/14/2024$14.15$14.25+0.71%$14.50$14.04264,304 shs$1.28 billion02/13/2024$14.65$14.15-3.41%$14.51$13.96571,017 shs$1.27 billion02/12/2024$14.42$14.65+1.60%$14.79$14.241.11 million shs$1.32 billion02/09/2024$14.70$14.42-1.90%$15.00$14.202.68 million shs$1.30 billion02/08/2024$14.71$14.70-0.07%$15.08$14.56507,663 shs$1.32 billion Related Companies: ZLAB Stock Chart KURA Stock Chart TARO Stock Chart SUPN Stock Chart SDGR Stock Chart DVAX Stock Chart AKRO Stock Chart HRMY Stock Chart PTGX Stock Chart MORF Stock Chart Receive AVDL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Avadel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVDL) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avadel Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.